It has been shown that blockade of Rho kinase with pharmacologic inhibitors inhibits renal fibrosis. This study examined the role of Rho kinase in renal fibrosis in the unilateral ureteral obstruction (UUO) model in mice that do not express the ROCK1 gene, a critical downstream mediator of Rho GTPase. Unexpected, real-time PCR, Western blot, and immunohistochemistry demonstrated that, compared with the wild-type mice, mice with ROCK1 knockout (KO) were not protected against renal fibrosis at both the early (day 5) and late (day 10) UUO, as determined by histology and expression of both mRNA and protein levels of ␣-smooth muscle actin, collagen types I and III, and fibronectin within the diseased kidney. Then the mechanisms of loss of protective effect on renal fibrosis in ROCK1 KO mice were investigated. It is interesting that mice that lacked ROCK1 did not have altered expression of ROCK2 but significantly increased TGF-␤ expression and Smad2/3 activation (phosphorylation and nuclear translocation) in the diseased kidney at day 5, which remained high at day 10 of UUO. Similarly, primary cultures of kidney fibroblasts that were obtained from both ROCK1 wild-type and KO mice showed that deletion of ROCK1 did not prevent TGF-␤-induced activation of Smad2/3 and collagen I expression. This also was observed in the presence of Rho kinase inhibitor Y-27632. Taken together, results from this study suggest that Rho/Rho kinase may not be a necessary or a central pathway for renal fibrosis in the UUO model. The interplay between the Rho/Rho kinase pathway and the Smad signaling pathway may be a key mechanism by which loss of ROCK1 does not prevent renal fibrosis in the UUO model.
merging evidence shows that TGF-␤ and its signaling molecules, Smads, play a critical role in renal fibrosis in both experimental and human chronic kidney diseases (1) (2) (3) . It now is established that TGF-␤ regulates fibrosis positively by receptor-associated Smads, including Smad2 and Smad3, but negatively by an inhibitory Smad7. In the context of renal fibrosis, both Smad2 and Smad3 are strongly activated in experimental and human diabetic kidney diseases (4, 5) and in the rat models of obstructive kidney disease (6,7) and five-sixths nephrectomy (8) . Inhibition of renal fibrosis by blocking activation of Smad2 and Smad3 with overexpression of Smad7 demonstrates a critical role for TGF-␤ signaling in renal fibrosis (5) (6) (7) (8) (9) (10) .
Recently, a number of studies have shown that Rho and its downstream effector, Rho kinase, are potential mediators of TGF-␤-associated renal fibrosis (11) (12) (13) (14) (15) (16) (17) . Rho is a small GTPase that is bound to GDP when latent and is bound to GTP when active (18, 19) . Together with its downstream effector, Rho-associated coiled-coil forming protein serine/threonine kinase (Rho kinase or Rock), Rho has been implicated in a wide variety of cellular functions (18, 19) . In addition to TGF-␤, the Rho/Rho kinase signaling cascade is activated by fibrogenic growth factors angiotensin II (20) , PDGF (21) , and endothelin-I (22) . Evidence for the potential role of the Rho kinase pathway in renal fibrosis comes from studies that used pharmacologic inhibition of the Rho/Rho kinase signaling pathway with selective inhibitors Y-27632 and fasudil (11) (12) (13) (14) (15) (16) (17) . With the use of these agents, the Rho/Rho kinase pathway also has been shown to play an important role in epithelial-mesenchymal transition (15, 23, 24) , cardiovascular diseases (25-27), and liver fibrosis (28, 29) .
Although pharmacologic inhibition of Rho kinase has been shown to be protective against renal fibrosis, the biologic functions of Rho kinase have not been well characterized. Therefore, we examined the functional role of ROCK1, an isoform of Rho kinase, in the pathogenesis of renal fibrosis in a model of unilateral ureteral obstruction (UUO) in mice that have genetic deletion of ROCK1 gene.
Materials and Methods

Generation of ROCK1 Knockout Mice
ROCK1 knockout (KO) mice were generated as described previously (30) . ROCK1 ϩ/Ϫ heterozygous mice then were intercrossed to produce homozygous ROCK1 Ϫ/Ϫ mice. The genotypes of the offspring were identified by Southern blot analysis ( Figure 1A ) and PCR on DNA that was obtained from tails of adult mice as described previously (31) . Disruption of the ROCK1 gene also was confirmed by Western blot analysis with multiple antibodies as described previously (30) . In addition, deletion of ROCK1 gene within the diseased kidney of UUO was confirmed by Western blot with the anti-ROCK1 antibody ( Figure 1B ). Mice used in our study had been backcrossed to FVB for at least six generations. The ROCK1 wild-type (WT) and KO mice with FVB background were used in this study. Homozygous ROCK1 KO mice were viable with neither detectable anatomic abnormalities nor increase in morbidity or mortality, although they were underrepresented (30) .
Obstructive Kidney Disease Model
A UUO kidney disease model was induced in both WT and ROCK1 KO mice (20 g body wt, 2 mo of age) by left ureteral ligation as described previously (6, 32) . For investigation of the role of ROCK1 in the early and late time points of obstructive kidney disease, groups of eight ROCK1 KO mice and seven WT mice were killed on day 5 and groups of 11 KO mice and seven WT mice were killed on day 10 after the left ureteral ligation. In addition, groups of six normal KO and six WT mice at the same age were used as normal controls. The experimental procedures were approved by Animal Experimental Committee at Baylor College of Medicine. Kidney tissue samples were collected at day 5 and day 10 after UUO for histology, immunohistochemistry, Western blot, and real-time PCR analyses.
Histology and Immunohistochemistry
Changes in renal morphology were examined in methyl Carnoy'sfixed, paraffin-embedded tissue sections (4 m) stained with hematoxylin and eosin or periodic acid-Schiff. To retrieve the antigens, 4-m paraffin sections were microwaved in 0.01 M citrate buffer for 10 min as described previously (6, 31, 33) . Sections then were incubated with a mouse mAb against ␣-smooth muscle actin (␣-SMA; Sigma, St. Louis, MO); rabbit polyclonal antibodies to phosphorylated Smad2/3, TGF-␤1, fibronectin (Santa Cruz Biotechnology, Santa Cruz, CA); and goat polyclonal antibodies to collagen I and III (Southern Tech, Birmingham, AL) using a three-layer peroxidase anti-peroxidase method (6, 8) . Sections then were developed with diaminobenzidine to produce a brown color, counterstained with hematoxylin, and coverslipped in an aqueous mounting medium. An isotype-matched mouse mAb (73.5) that recognized human CD45R antigen and goat or rabbit IgG (Sigma) were used as negative controls throughout the study.
Western Blot and Immunoprecipitation Analyses
Protein from kidney tissues was extracted with RIPA lysis buffer (1% Nonidet P-40, 0.1% SDS, 1 mM PMSF, 0.5% sodium deoxycholate, 1 mM sodium orthovanadate, and 1 mM sodium fluoride in PBS). After determination of protein concentrations, 20 g of the protein was mixed with an equal amount of 2ϫ SDS loading buffer (100 mM Tris-HCl, 4% SDS, 20% glycerol, and 0.2% bromophenol blue) for Western blot analysis as described previously (6, 8) . Briefly, samples were heated at 99°C for 5 min and then transferred to a polyvinylidene difluoride membrane. Nonspecific binding to the membrane was blocked for 1 h at room temperature with 5% BSA in Tris-buffered saline buffer (20 mM Tris-HCl, 150 mM NaCl, and 0.1% Tween 20) . The membranes were then incubated overnight at 4°C with primary antibodies, including mouse mAb against ␣-SMA (Santa Cruz); goat antibodies against collagen I and III; and rabbit antibodies to fibronectin, TGF-␤1, ROCK1, ROCK2 (Santa Cruz), and glyceraldehyde-3-phos- phate dehydrogenase (GAPDH; Chemicon, Temecula, CA). After washing, the membrane was incubated with a peroxidase-conjugated goat anti-mouse IgG or swine anti-goat (or rabbit) IgG in 1% BSA/Trisbuffered saline buffer. Phosphorylated Smad2/3 was determined by immunoprecipitation with anti-Smad2/3 antibody (Santa Cruz) followed by immunoblotting and detection with rabbit anti-phosphoserine antibody (6, 8) . The signals were visualized by an enhanced chemiluminescence system (Amersham, Piscataway, NJ).
Real-Time PCR
Total kidney RNA was isolated using the RNeasy kit, according to the manufacturer's instructions (Qiagen, Valencia, CA). The cDNA was synthesized as described previously (32) . Real-time PCR was run with the Opticon real-time PCR machine (MJ Research, Waltham, MA). The specificity of real-time PCR was confirmed via routine agarose gel electrophoresis and Melting-curve analysis. Housekeeping gene GAPDH was used as an internal standard. The primers used in this study are as follows: ␣-SMA, forward 5Ј-ACTGGGACGACATG-GAAAAG-3Ј, reverse 5Ј-CATCTCCAGAGTCCAGCACA-3Ј; collagen I, forward 5Ј-GAGCGGAGAGTACTGGATCG-3Ј, reverse 5Ј-TACTC-GAACGGGAATCCATC-3Ј; collagen III, forward 5Ј-TGGTCCT-CAGGGTGTAAAGG-3Ј, reverse 5Ј-GTCCAGCATCACCTTTTGGT-3Ј; fibronectin, forward 5Ј-ACACGGTTTCCCATTACGCCAT-3Ј, reverse 5Ј-AATGACCACTGCCAAAGCCCAA-3Ј; and GAPDH, forward 5Ј-TGCTGAGTATGTCGTGGAGTCTA-3Ј and reverse 5Ј-AGTGGGAGT-TGCTGTTGAAATC-3Ј. Ratios for ␣-SMA/GAPDH, collagen I/GAPDH, collagen III/GAPDH, and fibronectin/GAPDH were calculated for each sample and expressed as the means Ϯ SEM.
Quantitative Analyses
Smad2/3 activation was determined by the extent of its nuclear localization in stained tissue using antiphosphorylated Smad2/3 antibody. The number of positive cells for activated Smad2/3 was counted in 20 consecutive tubulointerstitial areas under high-power fields (ϫ40) by means of a 0.25-mm 2 graticule fitted in the eyepiece of the microscope, excluding the glomerulus and big vessels, and expressed as cells/cm 2 . The degree of TGF-␤1 expression and accumulation of ␣-SMA, collagen types I and III, and fibronectin in the entire cortical tubulointerstitium (a cross-section of the kidney) were determined using quantitative Image Analysis System (Optima 6.5; Media Cybernetics, Silver Spring, MD) as described previously (6,8). Briefly, the Figure 3 . Effect of deletion of ROCK1 on extracellular matrix (ECM) mRNA expression in the UUO model. Real-time PCR shows that compared with normal mice, a marked increase in ECM mRNA expression including ␣-smooth muscle actin (␣-SMA; A), collagen types I (B) and III (C), and fibronectin (D), is evident in the obstructive kidney in both WT and KO mice at both day 5 and day 10 after UUO (all P Ͻ 0.05). However, mice that lack ROCK1 show no protection against ECM mRNA expression. Note that deletion of ROCK1 significantly enhances collagen III expression at UUO kidney at day 5 compared with the WT UUO mice (C). Each bar represents the mean Ϯ SEM for at least six mice. Immunohistochemistry shows that ␣-SMA-positive myofibroblasts are apparent in tubulointerstitium, resulting in severe tubulointerstitial fibrosis in both WT and KO mice in the diseased kidney at day 5 and day 10 after UUO compared with normal WT or KO mice (P Ͻ 0.001; A and B). However, compared with the diseased WT mice (C and E), deletion of ROCK1 shows no protection against ␣-SMA-positive cell accumulation within the diseased kidney at both day 5 and day 10. Each bar represents the mean Ϯ SEM for at least 6 mice. Magnification, ϫ200.
examined area of the tubulointerstitium was outlined, positive staining patterns were identified, and the percentage of positive area in the examined tubulointerstitium was measured. Data are expressed as percentage as positive area examined. All scoring was performed in a blinded manner on coded slides.
In Vitro Studies
To study the mechanisms by which ROCK1 mediates renal fibrosis, we isolated kidney fibroblasts, a key cell type in the pathogenesis of renal fibrosis, from normal renal cortex of ROCK1 WT and KO mice. Briefly, under sterile condition, the cortex of mouse kidney was collected, minced, and digested with Liberase Blenzyme 3 (0.3 mg/ml; Roche, Palo Alto, CA) for 2 h. The pellet was incubated in DMEM that contained 10% FBS for 4 h, and then the nonadherent cells were removed. More than 85% of adherent cells were kidney fibroblasts as identified by elongated morphology and positive for the anti-fibroblast-specific protein 1 antibody (Abcam, Cambridge, MA). Cells under passage 3 were used for the experiments.
Primary renal fibroblasts were incubated in DMEM that contained 10% FBS until confluent. After serum starvation for 24 h, the cells were stimulated with TGF-␤1 (2.5 ng/ml; R&D Systems, Minneapolis, MN) in the presence or absence of Y-27632 (140 nM; Sigma) for 30 min for examination of Smad2/3 phosphorylation and for 24 h for detection of collagen type 1 by Western blot analysis as described in Western Blot and Immunoprecipitation Analyses. Effect of Y-27632 on inhibition of TGF-␤-induced (2.5 ng/ml) Rho kinase activities was confirmed by the MBL Rho kinase Assay Kit (CY-1160) following the manufacturer's instruction (CycLex Co., Ltd, Negano, Japan). Immunohistochemistry shows that a marked increase in tubulointerstitial collagen I accumulation is associated with severe tubulointerstitial fibrosis in both WT and KO mice at day 5 and day 10 after UUO compared with normal mice (P Ͻ 0.001; A and B). However, compared with the diseased WT mice (C and E), deletion of ROCK1 shows no protection against tubulointerstitial collagen II expression within the diseased kidney at both day 5 and day 10. Note that deletion of ROCK1 results in a significant increase in collagen I expression at day 5 after UUO (D and G). *P Ͻ 0.05 versus the time-matched mice. Each bar represents the mean Ϯ SEM for at least six mice. Magnification, ϫ200. Immunohistochemistry shows that a marked increase in tubulointerstitial collagen III accumulation is associated with severe tubulointerstitial fibrosis in both WT and KO mice at day 5 and day 10 after UUO, when compared with normal mice (P Ͻ 0.001; A and B). However, compared with the diseased WT mice (C and E), deletion of ROCK1 shows no protection against tubulointerstitial collagen III expression within the diseased kidney at both day 5 and day 10. Note that deletion of ROCK1 results in a significant increase in collagen III expression at day 5 after UUO (D and G). *P Ͻ 0.05 versus the time-matched animals. Each bar represents the mean Ϯ SEM for at least six mice. Magnification, ϫ200.
Statistical Analyses
Data that were obtained from this study are expressed as the mean Ϯ SEM. Statistical analyses were performed using one-way ANOVA from GraphPad Prism 3.0 (GraphPad Software, San Diego, CA).
Results
Histologic Injury
On periodic acid-Schiff-stained sections, kidney histology was normal in both normal WT and KO mice (Figure 2, A  and B) . Five days after the left ureteral ligation, WT mice developed severe tubulointerstitial damage, including tubular atrophy and interstitial fibrosis ( Figure 2C) . Unexpected, ROCK1 KO mice also exhibited a similar degree of severe tubulointerstitial damage ( Figure 2D ), demonstrating no protection from renal fibrosis in the ROCK1 KO mice. Similar results also were found in both WT and KO mice at day 10 after UUO ( Figure 2, E and F) .
Effect of Deletion of ROCK1 on Extracellular Matrix mRNA Expression
Consistent with the histologic findings, compared with the normal kidney, real-time PCR demonstrated that a 10-to 20-fold increase in mRNA expression of ␣-SMA, collagen I, collagen III, and fibronectin was found in the diseased kidney in both WT and KO mice at day 5 and day 10 after UUO (all P Ͻ 0.05; Figure 3 ). It is interesting that deletion of ROCK1 reduced (but not significantly) ␣-SMA mRNA expression and significantly increased collagen III mRNA at day 5 after UUO ( Figure  3 , A and C). However, there was no difference in the levels of increased extracellular matrix (ECM) mRNA expression of ␣-SMA, collagen types I or III, or fibronectin within the diseased kidney between the WT and KO mice at day 10 after UUO (all P Ͼ 0.05; Figure 3) .
Effect of Deletion of ROCK1 on ECM Protein Expression
Similar to the results found in mRNA expression, immunohistochemistry showed that compared with the normal kidney, a marked increase in accumulation of ␣-SMA, collagen I, col- Immunohistochemistry shows that a marked increase in tubulointerstitial fibronectin expression is associated with severe tubulointerstitial fibrosis in both WT and KO mice at day 5 and day 10 after UUO, when compared with normal mice (P Ͻ 0.001; A and B). However, deletion of ROCK1 shows no protection against tubulointerstitial fibronectin expression within the diseased kidney at both day 5 and day 10, when compared with the diseased WT mice (C and E). Moreover, deletion of ROCK1 results in a significant increase in fibronectin expression at day 5 after UUO (D and G). ***P Ͻ 0.001 versus the time-matched mice. Each bar represents the mean Ϯ SEM for at least six mice. Magnification, ϫ200. Western blot analysis shows that there is a significant increase in the levels of ␣-SMA, collagen III, and fibronectin (FN) expression in both ROCK1 KO and WT UUO kidney at day 5. However, deletion of ROCK1 does not alter the levels of ␣-SMA, collagen III, and FN expression within the obstructive kidney compared with the diseased WT mice (all P Ͼ 0.05). Each band represents one mouse kidney from either normal or diseased mice. Each bar represents the mean Ϯ SEM for at least five mice. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 versus normal mice.
lagen III, and fibronectin occurred in the UUO kidney in both WT and KO mice at day 5 and day 10 after UUO (all P Ͻ 0.001; Figures 4 through 7) . However, compared with the WT mice, ROCK1 KO mice were not protected against renal fibrosis as demonstrated by similar accumulation of tubulointerstitial ␣-SMA, collagen types I and III, and fibronectin within the diseased kidney at day 10 (P Ͼ 0.05; Figures 4 through 7 , E through G). Unexpected, deletion of ROCK1 significantly enhanced collagen I, collagen III, and fibronectin accumulation at day 5 after UUO ( Figures 5 through 7, C, D, and G) .
Effect of deletion of ROCK1 on ECM protein expression in the entire obstructive kidney also was determined by Western blot analysis of total kidney proteins. As shown in Figures 8  and 9 , accumulation of ␣-SMA, collagen types I and III, and fibronectin largely was increased in the UUO kidney at day 5 and day 10 in both WT and KO mice (all P Ͻ 0.01), whereas there was no difference in the extent of increased ECM expression in the diseased kidney between WT and KO animals (all P Ͼ 0.05).
Mechanisms of Deletion of ROCK1 Fail to Prevent Renal Fibrosis in Obstructive Kidney
We next examined the mechanisms by which deletion of ROCK1 fails to prevent renal fibrosis in the obstructive kidney by examining the expression of ROCK2. As shown in Figure 10 , Western blot analysis demonstrated an increase, although not statistically significant, in the expression of ROCK2 in the obstructive kidney at day 10 in both WT and KO mice. However, deletion of ROCK1 did not alter the levels of ROCK2 expression compared with the diseased WT mice (P Ͼ 0.05).
We then asked whether the loss of protective effect on renal fibrosis in ROCK1 KO mice is associated with TGF-␤ expression. Immunohistochemistry and Western blot analyses showed that expression of TGF-␤1 protein was markedly upregulated in the UUO kidney in both WT and KO mice at day 5 and day 10 ( Figures 11 and 12) . Upregulation of TGF-␤1 was confined largely in the tubulointerstitium of the UUO kidney, where severe tubulointerstitial fibrosis was evident ( Figure 11, C through F) . It is interesting that Western blot analysis demonstrated that deletion of ROCK1 significantly enhanced renal TGF-␤1 protein expression at day 5 after UUO when compared with the diseased WT animals ( Figure 12A ). However, when disease became progressive at the later time point on day 10, levels of TGF-␤1 expression within the diseased kidney between WT and KO mice were not significantly different ( Figure 12B) .
We next examined activation of the TGF-␤/Smad signaling pathway within the diseased kidney by Western blot and immunohistochemistry. As shown in Figures 12 and 13 , both Smad2/3 phosphorylation (p-Smad2/3) and nuclear translocation were markedly increased in the UUO kidney in both WT and KO mice at day 5 and day 10. Importantly, deletion of ROCK1 significantly enhanced further phosphorylation levels Figure 9 . Effect of deletion of ROCK1 on ECM expression in UUO model at day 10 demonstrated by Western blot analysis. Western blot analysis shows that there is a significant increase in the levels of ␣-SMA, collagen I, collagen III, and FN expression in both ROCK1 KO and WT UUO kidney at day 10. However, deletion of ROCK1 does not alter the levels of ␣-SMA, collagen I and III, and FN expression within the obstructive kidney, when compared with the diseased WT mice (all P Ͼ 0.05). Each band represents one mouse kidney from either normal or diseased mice. Each bar represents the mean Ϯ SEM for at least five mice. ** P Ͻ 0.01, ***P Ͻ 0.001 versus normal animals. Figure 10 . Effect of deletion of ROCK1 on ROCK2 expression in UUO model. Western blot analysis shows that compared with the normal mice, an increase in expression of ROCK2 is evident in the diseased kidney at day 10 after UUO, but this is not statistically significant. However, deletion of ROCK1 does not alter the level of ROCK2 expression within the diseased kidney at day 10 compared with the WT mice. Each band represents one mouse kidney from either normal or diseased mice. Each bar represents the mean Ϯ SEM for at least five mice.
of p-Smad2/3 ( Figure 12 ) and p-Smad2/3 nuclear translocation within the diseased kidney at day 5 and day 10 after UUO ( Figure 13 ), demonstrating that deletion of ROCK1 enhanced Smad signaling in the obstructed kidney.
To confirm whether deletion of ROCK1 can influence the TGF-␤/Smad signaling pathway, we isolated kidney fibroblasts, a major cell type in production of collagen matrix, from the normal renal cortex of ROCK1 KO and WT mice and stimulated them with TGF-␤1 in the presence or absence of Rho kinase inhibitor Y-27632. As shown in Figure 14 , deletion of ROCK1 did not prevent TGF-␤-induced p-Smad2/3 and collagen I expression. Unexpected, addition of Rho kinase inhibitor produced no inhibitory effect on either p-Smad2/3 or collagen I expression in response to TGF-␤1, although it inhibited TGF-␤-induced Rho kinase activities in a dose-dependent manner (30 to 50% reduced) as determined by the Rho Kinase Assay Kit.
Discussion
This study showed that deletion of ROCK1 was not protective against renal fibrosis in a mouse model of UUO. Moreover, deletion of ROCK1 enhanced further collagen matrix and fibronectin expression within the diseased kidney at day 5 after Immunohistochemistry shows that TGF-␤1 is strongly expressed in normal glomeruli but not in tubulointerstitium in both normal WT and KO mice (A and B). In contrast, marked upregulation of TGF-␤1 is found in the tubulointerstitial area with severe fibrosis in both WT and KO mice at day 5 and day 10 after UUO (C through G). Compared with the WT mice, deletion of ROCK1 does not alter the levels of TGF-␤1 expression within the normal and the diseased kidney at both day 5 and day 10 after UUO. Each bar represents the mean Ϯ SEM for at least six mice. Magnification, ϫ200 Figure 12 . Effect of deletion of ROCK1 on TGF-␤ expression and Smad2/3 phosphorylation in UUO model at day 5 (A) and day 10 (B) mice. Western blot analysis shows that compared with normal controls, there is a significant increase in TGF-␤1 expression and Smad2/3 phosphorylation in the obstructive kidney. It is interesting that compared with the WT mice, deletion of ROCK1 shows a further increase in TGF-␤1 expression within the diseased kidney at day 5 and day 10, which is associated with a significant increase in the level of Smad2/3 phosphorylation (p-S2/3). Each band represents one mouse kidney from either normal or diseased mice. Each bar represents the mean Ϯ SEM for normal (n ϭ 4), diseased WT (n ϭ 6), and diseased KO (n ϭ 6) mice. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 versus normal; # P Ͻ 0.05, ## P Ͻ 0.01 versus as indicated.
UUO, although no significant difference in the kidney histology and fibrogenic parameters, including ␣-SMA, collagen types I and III, and fibronectin, was observed in both ROCK1 KO and WT mice at day 10 after UUO. These findings indicate that the Rho kinase pathway may not be a key pathway in the pathogenesis of renal fibrosis as previously thought. ROCK1 and ROCK2 are isoforms of Rho kinase, both of which are active in cytoskeletal arrangement (18, 19) , cardiovascular remodeling (20, (25) (26) (27) , liver fibrosis (28, 29) , and epithelial-mesenchymal transition (15, 23, 24) . Evidence for the role of Rho kinase in renal fibrosis comes from recent reports that the use of selective inhibitors for both isoforms of Rho kinase, Y-27632 and Fasudil, is able to inhibit tubulointerstitial fibrosis in the mouse model of UUO nephropathy (11, 12) , ischemia/ reperfusion-induced acute renal failure (13) , and glomerulosclerosis in spontaneous hypertensive rats (14) . Unexpected, results that were obtained from our study did not support the findings as previously reported using pharmacologic inhibitors (11) (12) (13) (14) (15) and found that deletion of ROCK1 produced no protective effect on renal fibrosis in UUO. The use of specific targeting of the ROCK1 gene in our study versus the use of pharmacologic inhibitors in the others may be the major reason for this discrepancy. It is possible that the use of Rho kinase inhibitors is able to inhibit both ROCK1 and ROCK2 activities, thereby inhibiting renal fibrosis, whereas specific deletion of ROCK1 gene alone may not be adequate to prevent fibrosis in the UUO model. Could the failure of ROCK1 deletion to protect against renal fibrosis stem from an increase in ROCK2 activities? Using Western blot analysis of diseased kidneys, we showed that deletion of ROCK1 did not alter expression of ROCK2. This is consistent with the finding that expression of ROCK2 does not increase to compensate for the loss of ROCK1 deletion in the ROCK1 KO mice, although deletion of ROCK1 exhibits a protective effect on cardiac fibrosis (30) . Nevertheless, the interplay between the ROCK1 and ROCK2 pathways Immunohistochemistry shows that there is a marked increase in nucleated p-Smad2/3 in both WT and KO mouse kidney after UUO at day 5 and day 10 compared with the normal kidney (all P Ͻ 0.001). Note that compared with the WT mice (C and E), deletion of ROCK1 does not alter the levels of nucleated p-Smad2/3 in the normal mouse kidney (A, B, and G), but significantly enhances p-Smad2/3 nuclear location in the diseased kidney at day 5 and day 10 after UUO (D, F, and G). Each bar represents the mean Ϯ SEM for at least 6 mice. **P Ͻ 0.01, ***P Ͻ 0.001 versus WT mice at time-matched mice. Magnification, ϫ200. Results show that additional TGF-␤1 (2.5 ng/ml) causes a marked Smad2/3 phosphorylation and collagen I expression in both ROCK1 KO and WT kidney fibroblasts (all P Ͻ 0.05), which is not blocked by addition of Rho kinase inhibitor (Y-27632, 140 nM; P Ͼ 0.05). **P Ͻ 0.01 versus normal mice. Data represent the mean Ϯ SEM for at least three independent experiments.
in terms of renal fibrosis in obstructive kidney disease remains largely unknown. It remains unclear whether deletion of both ROCK1 and ROCK2 may be required for protection from tubulointerstitial fibrosis, as is accomplished by the pharmacologic inhibition of Rho kinase by Y-27632 or fasudil. Alternatively, compared with studies that used Rho kinase inhibitors, the inability of deletion of ROCK1 to prevent renal fibrosis also may indicate that the Rho kinase inhibitors may not be entirely specific in inhibition of Rho kinase activities or may have additional activities beyond the selective inhibition of Rho kinase. In addition, the failure of deletion of ROCK1 to prevent UUO kidney from fibrosis is inconsistent with the finding in a pressure overload heart model in the same phenotype of mice (30) . This may be associated with the nature of disease in which the UUO model is much more aggressive compared with the pressure overload heart model.
A wide array of studies have established that TGF-␤ signals through its downstream Smad signaling pathway to mediate renal fibrosis (1) (2) (3) (4) . Blockade of Smad2/3 activation by overexpressing an inhibitory Smad7 inhibits renal fibrosis in rat models of UUO and remnant kidney disease (6 -8) . The finding that mice null for Smad3 are protected against obstructive nephropathy indicates that Smad signaling plays a critical role in renal fibrosis (34) . Beyond the Smad signaling pathway, Rho kinase also has been identified as a non-Smad-dependent pathway and plays a role in fibrosis in response to TGF-␤ (35) . In addition to the Smad signaling pathway, it has been shown that TGF-␤ is able to activate the Rho/Rho kinase pathway to induce epithelial-mesenchymal transition and cell growth arrest involving an initial inhibition of Cdc25A enzymatic activity (36). This is followed by upregulation of Cdk inhibitory proteins and downregulation of c-Myc and Cdc25A (36) . In addition, the Rho/Rho kinase pathway is important in TGF-␤-mediated Smad-dependent growth inhibition in human MCF10CA1h breast carcinoma cells (35) . It is interesting that treatment of MCF10CA1h cells with the Rho kinase inhibitor Y27632 alone significantly increases the basal levels of phosphorylated Smad3 (35) . This suggests that the Rho/Rho kinase pathway negatively regulates the TGF-␤/Smad signaling. This observation leads us to hypothesize that the failure of a protective effect on renal fibrosis in mice that lack ROCK1 may be associated with the enhancement of TGF-␤/Smad signaling. Indeed, expression of TGF-␤1 was markedly upregulated in the obstructive kidney in both WT and KO mice. Importantly, at the early time point of UUO at day 5, we found that deletion of ROCK1 caused a further increase in TGF-␤1 expression, thereby enhancing further TGF-␤/Smad signaling as demonstrated by an increase in phosphorylation of Smad2/3 and p-Smad2/3 nuclear translocation and resulting in more severe renal fibrosis compared with WT mice. Therefore, an increase in TGF-␤/Smad signaling in ROCK1 KO mice with UUO may be a mechanism whereby deletion of ROCK1 produced no protective effect on renal fibrosis in obstructive kidney disease. This also is supported by the finding at the late time point of UUO at day 10 and by the in vitro finding that kidney fibroblasts that lack ROCK1 or addition of Rho kinase inhibitor could not prevent TGF-␤-induced Smad2/3 activation and collagen matrix production. Taking together, these findings suggest that there may be a redundant mechanism between the Rho/Rho kinase pathway and the TGF-␤/Smad signaling pathway in TGF-␤-mediated renal fibrosis in the UUO model. Deletion of ROCK1 may result in an increase in expression of TGF-␤-and Smad-dependent renal fibrosis. This may be one mechanism by which ROCK1 KO fails to exhibit its protective role on renal fibrosis in the UUO model. However, our study cannot exclude the role of ROCK2 in renal fibrosis. Future study with ROCK2 KO is needed to confirm the role of the Rho/Rho kinase pathway in renal fibrosis in vivo.
